These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In Parkinson's disease STN stimulation enhances responsiveness of movement initiation speed to high reward value. Kojovic M; Higgins A; Jahanshahi M Neuropsychologia; 2016 Aug; 89():273-280. PubMed ID: 27371365 [TBL] [Abstract][Full Text] [Related]
6. Influence of promised rewards on conflict resolution in healthy participants and patients with Parkinson's disease. Houvenaghel JF; Duprez J; Naudet F; Argaud S; Dondaine T; Drapier S; Robert GH; Drapier D; Vérin M; Sauleau P J Neurol Sci; 2016 Aug; 367():38-45. PubMed ID: 27423562 [TBL] [Abstract][Full Text] [Related]
7. Improved cognition while cycling in Parkinson's disease patients and healthy adults. Hazamy AA; Altmann LJP; Stegemöller E; Bowers D; Lee HK; Wilson J; Okun MS; Hass CJ Brain Cogn; 2017 Apr; 113():23-31. PubMed ID: 28088064 [TBL] [Abstract][Full Text] [Related]
8. The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate. Drijgers RL; Verhey FR; Tissingh G; van Domburg PH; Aalten P; Leentjens AF J Neurol Sci; 2012 Sep; 320(1-2):121-6. PubMed ID: 22824349 [TBL] [Abstract][Full Text] [Related]
9. Intraindividual variability in neurocognitive speed: a comparison of Parkinson's disease and normal older adults. de Frias CM; Dixon RA; Fisher N; Camicioli R Neuropsychologia; 2007 Jun; 45(11):2499-507. PubMed ID: 17507058 [TBL] [Abstract][Full Text] [Related]
10. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions. Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442 [TBL] [Abstract][Full Text] [Related]
13. Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication. Kojovic M; Mir P; Trender-Gerhard I; Schneider SA; Pareés I; Edwards MJ; Bhatia KP; Jahanshahi M J Neurol; 2014 Jun; 261(6):1080-9. PubMed ID: 24687892 [TBL] [Abstract][Full Text] [Related]
14. Elderly adults show higher ventral striatal activation in response to motor performance related rewards than young adults. Widmer M; Stulz S; Luft AR; Lutz K Neurosci Lett; 2017 Nov; 661():18-22. PubMed ID: 28939388 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients. Bogdanov M; LoParco S; Otto AR; Sharp M Neurobiol Learn Mem; 2022 Sep; 193():107652. PubMed ID: 35724812 [TBL] [Abstract][Full Text] [Related]
16. Anticipating social incentives recruits alpha-beta oscillations in the human substantia nigra and invigorates behavior across the life span. Sobczak A; Repplinger S; Bauch EM; Brueggemann N; Lohse C; Hinrichs H; Buentjen L; Voges J; Zaehle T; Bunzeck N Neuroimage; 2021 Dec; 245():118696. PubMed ID: 34732325 [TBL] [Abstract][Full Text] [Related]
17. Feedback-based versus observational classification learning in healthy aging and Parkinson's disease. Schmitt-Eliassen J; Ferstl R; Wiesner C; Deuschl G; Witt K Brain Res; 2007 Apr; 1142():178-88. PubMed ID: 17300759 [TBL] [Abstract][Full Text] [Related]
18. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease. Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374 [TBL] [Abstract][Full Text] [Related]
19. The effect of motivation on movement: a study of bradykinesia in Parkinson's disease. Shiner T; Seymour B; Symmonds M; Dayan P; Bhatia KP; Dolan RJ PLoS One; 2012; 7(10):e47138. PubMed ID: 23077557 [TBL] [Abstract][Full Text] [Related]